Beta agonists and the asthma paradox. - Wikidata - awgldk - TriplyDB

Beta agonists and the asthma paradox.

Beta agonists and the asthma paradox.

http://www.wikidata.org/entity/Q40711045

about

Beta agonists and the asthma paradox.

http://www.wikidata.org/entity/Q40711045

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Beta agonists and the asthma paradox.

@en

type

label

Beta agonists and the asthma paradox.

@en

prefLabel

Beta agonists and the asthma paradox.

@en

P1433

Q40711045-4D493476-8C62-48B8-B9BA-7CBE7B299E0D

P1476

Q40711045-EAD74FB9-95A8-46E9-A90D-F1F35E13DD76

P2093

Q40711045-F9BA9A8A-FFC1-4AE1-BFB6-13D7B05059FF

P2860

Q40711045-00958693-7AAB-46F3-B9C9-80E0A23AD717

Q40711045-34E7F101-E460-455D-A274-BB3A8144C5F5

Q40711045-461BC100-82C6-4178-BBAD-F04732699071

Q40711045-50A0DF42-2DBF-4E1B-9728-E6A035B393F2

Q40711045-57FB0F92-54EF-4DD1-BADA-1906600EE0C3

Q40711045-73E1810F-8385-4510-A53A-4345BF924814

Q40711045-867B5C57-117C-40E2-9953-EF0668E9BA5E

Q40711045-87287F94-1D6C-474E-93B0-AA70CEF57C26

Q40711045-8865319A-EFD4-4160-88E9-3010E4183AFD

Q40711045-89F96254-350B-443A-949E-818C7BCDFB89

P304

Q40711045-3A194FB9-D17D-4E8E-8CA2-BE57659FEE6B

P31

Q40711045-B07C2E0C-CCFA-40FF-B66B-494435AED099

P356

Q40711045-F187352C-F815-4658-BDE9-5C99AA218122

P407

Q40711045-341DC507-104D-4ACD-A2AE-1A7839A1CA29

P433

Q40711045-6BA843B8-F7C8-4E12-AF95-188FCE3089DE

P478

Q40711045-46BEE95F-FEAA-490B-8F41-A5E20D0E3894

P577

Q40711045-5A5FC74A-DB26-466D-BFBF-634868E4F3C5

P698

Q40711045-C7E248AF-71A8-4F62-98A9-725A26361A0A

P921

Q40711045-5E0A4C71-BA5B-45E7-B8DB-25D78BF7FAAC

P356

02770909309054513

P1433

Journal of Asthma

P1476

Beta agonists and the asthma paradox.

@en

P2093

Page CP

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease

The use of beta-agonists and the risk of death and near death from asthma.

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

International trends in hospital admission rates for asthma.

Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.

Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.

Is current treatment increasing asthma mortality and morbidity?

Increase in hospital admissions for childhood asthma: trends in referral, severity, and readmissions from 1970 to 1985 in a health region of the United Kingdom.

Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors.

P304

155-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02770909309054513

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1993-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8100814

http://www.w3.org/2001/XMLSchema#string

P921